We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFMD icon
2601
LifeMD
LFMD
$159M
$105K ﹤0.01%
21,138
MRSN
2602
DELISTED
Mersana Therapeutics
MRSN
$105K ﹤0.01%
2,926
+1,569
+116% +$81.2K
BWFG icon
2603
Bankwell Financial Group
BWFG
$542M
$105K ﹤0.01%
3,357
ABSI icon
2604
Absci
ABSI
$1.63B
$104K ﹤0.01%
39,857
-8,692
-18% -$30.6K
CCCC icon
2605
C4 Therapeutics
CCCC
$480M
$104K ﹤0.01%
28,854
-6,601
-19% -$32.8K
LILA icon
2606
Liberty Latin America Class A
LILA
$1.69B
$104K ﹤0.01%
23,969
-5,967
-20% -$32.7K
MVIS icon
2607
Microvision
MVIS
$111M
$103K ﹤0.01%
5,267
+1,661
+46% +$26.2K
RMAX icon
2608
RE/MAX Holdings
RMAX
$263M
$103K ﹤0.01%
9,695
OMF icon
2609
OneMain Financial
OMF
$7.44B
$103K ﹤0.01%
1,982
+5
+0.3% +$259
NPCE icon
2610
Neuropace
NPCE
$500M
$103K ﹤0.01%
+9,205
New +$80K
CTNM
2611
Contineum Therapeutics
CTNM
$564M
$103K ﹤0.01%
+7,029
New +$111K
CHMG icon
2612
Chemung Financial Corp
CHMG
$401M
$103K ﹤0.01%
2,107
BTMD icon
2613
Biote Corp
BTMD
$40.7M
$102K ﹤0.01%
16,582
BBBY
2614
Bed Bath & Beyond
BBBY
$403M
$102K ﹤0.01%
22,783
-5,390
-19% -$34.3K
ESSA
2615
DELISTED
ESSA Bancorp
ESSA
$102K ﹤0.01%
5,225
MEC icon
2616
Mayville Engineering Co
MEC
$596M
$102K ﹤0.01%
6,477
OLPX
2617
DELISTED
Olaplex Holdings
OLPX
$102K ﹤0.01%
58,679
+776
+1% +$1.54K
VEL icon
2618
Velocity Financial
VEL
$711M
$101K ﹤0.01%
5,187
RAPP
2619
Rapport Therapeutics
RAPP
$2.29B
$101K ﹤0.01%
5,710
TTSH
2620
DELISTED
Tile Shop Holdings
TTSH
$101K ﹤0.01%
14,601
+3,926
+37% +$26.2K
CHRS icon
2621
Coherus Oncology
CHRS
$181M
$101K ﹤0.01%
+73,099
New +$82K
EPM icon
2622
Evolution Petroleum
EPM
$134M
$101K ﹤0.01%
19,232
+13,270
+223% +$72.6K
RELL icon
2623
Richardson Electronics
RELL
$302M
$100K ﹤0.01%
7,144
ESI icon
2624
Element Solutions
ESI
$9.37B
$100K ﹤0.01%
3,931
+11
+0.3% +$297
GETY icon
2625
Getty Images
GETY
$124M
$99.4K ﹤0.01%
46,011
-14,227
-24% -$46.4K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.